HR. 1922In Committee
Ensuring Access to Essential Drugs Act
Exempts certain orally administered brand name drugs treated as generics under Medicaid rules from the Medicare Part D Manufacturer Discount Program
Plain-English overview
What this bill does
Exempts certain orally administered brand name drugs treated as generics under Medicaid rules from the Medicare Part D Manufacturer Discount Program
Key points
- Exempt certain oral brand name drugs
Current status
Where it stands
Status
In Committee
Latest action
2025-03-06 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedHealth